Skip to main content Accessibility help
×
Home

Information:

  • Access
  • Open access

Actions:

      • Send article to Kindle

        To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

        Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

        Find out more about the Kindle Personal Document Service.

        CHIP-Family intervention to improve the psychosocial well-being of young children with congenital heart disease and their families: results of a randomised controlled trial
        Available formats
        ×

        Send article to Dropbox

        To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

        CHIP-Family intervention to improve the psychosocial well-being of young children with congenital heart disease and their families: results of a randomised controlled trial
        Available formats
        ×

        Send article to Google Drive

        To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

        CHIP-Family intervention to improve the psychosocial well-being of young children with congenital heart disease and their families: results of a randomised controlled trial
        Available formats
        ×
Export citation

Abstract

Objective:

Children with congenital heart disease and their families are at risk of psychosocial problems. Emotional and behavioural problems, impaired school functioning, and reduced exercise capacity often occur. To prevent and decrease these problems, we modified and extended the previously established Congenital Heart Disease Intervention Program (CHIP)–School, thereby creating CHIP-Family. CHIP-Family is the first psychosocial intervention with a module for children with congenital heart disease. Through a randomised controlled trial, we examined the effectiveness of CHIP-Family.

Methods:

Ninety-three children with congenital heart disease (age M = 5.34 years, SD = 1.27) were randomised to CHIP-Family (n = 49) or care as usual (no psychosocial care; n = 44). CHIP-Family consisted of a 1-day group workshop for parents, children, and siblings and an individual follow-up session for parents. CHIP-Family was delivered by psychologists, paediatric cardiologists, and physiotherapists. At baseline and 6-month follow-up, mothers, fathers, teachers, and the child completed questionnaires to assess psychosocial problems, school functioning, and sports enjoyment. Moreover, at 6-month follow-up, parents completed program satisfaction assessments.

Results:

Although small improvements in child outcomes were observed in the CHIP-Family group, no statistically significant differences were found between outcomes of the CHIP-Family and care-as-usual group. Mean parent satisfaction ratings ranged from 7.4 to 8.1 (range 0–10).

Conclusions:

CHIP-Family yielded high program acceptability ratings. However, compared to care as usual, CHIP-Family did not find the same extent of statistically significant outcomes as CHIP-School. Replication of promising psychological interventions, and examination of when different outcomes are found, is recommended for refining interventions in the future.

Trial registry

Dutch Trial Registry number NTR6063, https://www.trialregister.nl/trial/5780.

Children with congenital heart disease (CHD) are at increased risk of a range of psychosocial problems. Therefore, the aim of the current study was to determine the effectiveness of an innovative psychosocial intervention, the Congenital Heart Disease Intervention Program (CHIP)–Family, in improving the psychosocial well-being of children with CHD and their families. The arguments for reducing psychosocial problems in these families are discussed below.

In children with CHD, emotional and behavioural problems may already emerge in infancy. 1 , 2 Compared with healthy children, pre-school and school-aged children with CHD have increased levels of internalising and externalising problems 3 8 and reduced levels of school performance. 5 , 7 , 9 Moreover, compared with healthy children, children with CHD more often require remedial teaching or special education 10 14 and face increased rates of grade repetition. 4 , 12 , 15 Impaired social functioning and social cognition have also been reported. 5 , 9 , 16 Children with CHD participate in fewer social activities 14 and are more often perceived to be withdrawn, not accepted by peers, and too dependent on others 9 . In adolescence and adulthood, CHD patients remain at increased risk of psychosocial difficulties. 17 22

As to physical activity levels of children with CHD, conflicting results have been reported. Several studies, including two systematic reviews, have reported reduced levels of physical activity in children with severe CHD. 23 26 However, others have found that physical activity levels of children with different CHD diagnoses do not differ from those of children from the general population. 27

It is increasingly recognised that parental mental well-being mediates psychosocial outcomes in children with CHD 4 , 9 and that family factors are more important predictors of psychosocial outcomes of children with CHD compared to medical factors. 28 , 29 Unfortunately, parents of children with CHD themselves are at increased risk of mental health problems, such as post-traumatic stress disorder, depression, and anxiety. 30 32

To prevent and decrease these difficulties in children with CHD and their families, a multidisciplinary, psychosocial intervention is needed. Research has demonstrated that families of children with CHD express a need for psychosocial care themselves. 33 , 34 Until now, the only evidence-based psychosocial intervention in this field was the CHIP-School program. 35 , 36 CHIP-School consisted of a multidisciplinary 1-day group workshop and individual follow-up session for parents of children with CHD who were entering school. The theoretical rationale of CHIP-School was derived from Thompson’s transactional stress and coping model. 37 This model states that the effect of an illness on a child’s well-being is mediated by familial coping and appraisal. The developers aimed to strengthen parental mental health and parenting skills, thereby indirectly increasing emotional resilience of children with CHD. CHIP-School yielded positive results with regard to maternal mental health, perceived strain on the family, and school absence of the child. With regard to child emotional and behavioural problems, no significant improvements were found. However, CHIP-School did not contain a specific child module. We reasoned that directly targeting both parents and children would improve the results previously obtained through CHIP-School.

Therefore, we have modified CHIP-School and added a specific child module focused on improving emotional well-being, sports enjoyment, and school functioning. As mothers, fathers, and siblings are also part of this innovate and extended intervention, the intervention is titled “CHIP-Family.” We hypothesised that participating in the CHIP-Family intervention would improve the psychosocial well-being of children with CHD and their parents, family functioning, and parents’ disease-specific knowledge.

Materials and methods

This single-blinded parallel randomised controlled trial was approved by the Medical Ethics Committee of the Erasmus Medical Center and adhered to the ethical guidelines of the Declaration of Helsinki. Before participation, written informed consent was obtained from all patients’ parents or legal guardians. A detailed description of the study protocol has been published previously. 38

Participants

Children and their families were recruited during a 1-year inclusion period (30 September 2016 to 12 September 2017) via the Erasmus Medical Center–Sophia Children’s Hospital, a tertiary referral centre for paediatric cardiology and cardiac surgery in the Netherlands, and nationally via the Dutch Patient Association for Congenital Heart Disease. Families of children who (1) underwent at least one invasive medical procedure for CHD (i.e., cardiac catheterisation and/or open heart surgery) and (2) were attending kindergarten or first or second year of primary school at the time of first assessment and were eligible for participation. Children with known intellectual impairment (intelligence quotient ≤ 70) were excluded, as a sufficient level of intelligence was required to participate in the child intervention program. Moreover, prematurely born children (i.e., gestational age at birth < 37 weeks) with no CHD other than a patent ductus arteriosus were excluded, as families of prematurely born children experience different psychosocial problems. 39 Lastly, sufficient mastery of the Dutch language was required.

Procedure

As to patients of the Erasmus Medical Center, eligibility was assessed by screening patient records of 2- to 8-year-old children who had undergone an invasive cardiac procedure or who had received cardiac follow-up. Subsequently, parents of children who seemed to be eligible received an information letter explaining the purpose and content of the study. As to members of the Dutch Patient Association for Congenital Heart Disease, for privacy reasons, no medical information was available. Therefore, information letters explaining the purpose and content of the study were sent to parents of all 2- to 8-year-old children.

If parents indicated to be interested in participation or did not respond within 2 weeks, eligibility was verified via a phone call. Before giving written informed consent, all families received a verbal explanation of the study and were invited to ask questions. Consequently, an independent researcher randomly assigned participants to the CHIP-Family intervention or care-as-usual control group, which only received medical care (allocation ratio 1:1). The researcher who collected all assessments and performed all analyses was blinded for randomisation outcome. Randomisation was stratified by school year (kindergarten versus primary school) and CHD severity. CHD severity was divided into limited to no residual heart defects versus mild to severe residual heart defects after cardiac intervention (see Table 1). This classification was made based on treatment-related aspects and intensity of cardiac follow-up. 40 Randomisation block size was fixed at four per stratification category. Due to logistical reasons in the starting phase of the project, the first four families who consented to participate were allocated to the CHIP-Family group without randomisation. We limited the period between baseline assessment and the intervention to 2 weeks. Moreover, parents had to be notified earlier that they had to make practical arrangements to be able to participate in the CHIP-Family workshop for an entire day. For these two important logistic reasons, parents of patients were informed of randomisation outcome prior to the baseline assessment. The follow-up assessment took place 6 months after baseline. The participation flow chart is shown in Fig 1.

Table 1. Stratification factor “Congenital Heart Disease Intervention Program (CHD) severity.”

1. Eighty-nine children and their families were randomly allocated to either the intervention group or the care-as-usual control group. The first four children and their families were directly allocated to the CHIP-Family intervention group.

Figure 1. Participation flow chart.

Intervention

The CHIP-Family is an adaptation and extension of the CHIP-School intervention. 36 CHIP-Family consisted of a 6-hour group workshop (three to five families per workshop) for parents and children and an individual 1-hour follow-up session per parent couple. The developers of the original CHIP protocol conducted a 1-day training for four senior licensed clinical and health psychologists and five junior psychologists to deliver the parent module of the CHIP-Family intervention. A senior psychologist trained the junior psychologists to provide the child module. During the parent workshops and child workshops (one student per workshop), protocol adherence was assessed through a standardised form by psychology master’s students. For privacy reasons and due to the group format of the CHIP-Family workshops, it was not possible to videotape or audiotape the workshops. With the consent of parents, protocol adherence of the individual follow-up sessions was assessed through audiotapes by psychology master’s students.

The 1-day parent workshop consisted of problem prevention therapy, psychoeducation, general parenting skills, skills specific to parenting a child with CHD (provided by two senior clinical psychologists for 4 hours), and medical issues (provided by a paediatric cardiologist supported by a senior clinical psychologist for 1 hour). The 1-hour lunch break gave families more opportunity to share their experiences.

As background information, parents received all slides that were presented in the workshop, the CHIP manual 41 containing all topics covered in the workshop, several information leaflets, and a home assignment on problem prevention therapy. Approximately 4 weeks after the workshop, each parent couple received an individual follow-up session provided by a senior psychologist who was present at the parent workshop and a psychologist who was present at the child workshop. The follow-up session focused on questions or worries of individual families, future coping strategies, and the problem prevention home assignment.

Whereas the CHIP-School intervention consisted of a parent module, the CHIP-Family module also comprised a specific child module. The child module consisted of a workshop that was held concurrently with the parent workshop. The child workshop consisted of cognitive behavioural exercises based on the evidence-based Fun FRIENDS protocol 42 , 43 and focused on strengthening self-esteem, regulating emotions, relaxation, problem-solving skills, and positive thinking (provided by two junior psychologists who were supervised by two senior clinical psychologists for 4 hours). The children also did sport exercises based on a standardised exercise program 44 specifically developed for children with CHD and their siblings (provided by a physiotherapist and assistant for 1 hour). Each child was allowed to bring a 4- to 10-year-old sibling or friend to normalise participation and to stimulate practice at home.

Thus, though predicated on a similar conceptual model, CHIP-Family differed from CHIP-School by having parallel modules/workshops for the whole family (children, siblings, and parents). In addition, CHIP-School included a bicycle exercise stress test. This was essentially a behavioural experiment to highlight to parents (in vivo and in the presence of a cardiologist) that vigorous exercise was safe with non-concerning electrocardiogram rhythms evident throughout. Unfortunately, it was not possible to include this in the current CHIP-Family intervention for logistic reasons.

Instruments

All questionnaires were completed by both parents at baseline and 6-month follow-up, unless otherwise specified. Teachers completed only the 6-month follow-up questionnaires, because some teachers did not know the child sufficiently at baseline to fill out the questionnaires. If a child had multiple teachers, questionnaires were completed by the teacher who knew the child the best or spent the most time with the child. Children completed two sports-related questions at baseline and 6-month follow-up. Validated Dutch versions of internationally well-known questionnaires with adequate psychometric properties were used. All questionnaires were completed through a secure online system. Demographic variables were assessed through the Rotterdam Quality of Life interview. 45

Child outcomes

Child emotional and behavioural problems were the primary child outcome and were assessed through the Child Behavior Checklist 46 1½-5 (100 items; for 4- and 5-year-olds) or Child Behavior Checklist 6-18 (120 items; for 6- to 8-year-olds).

Problem behaviour at school was assessed through the Teacher’s Report Form-C 46 1½-5 (100 items; for 4- and 5-year-olds) or the Teacher’s Report Form 6-18 47 (120 items; for 6- to 8-year-olds) which was completed by teachers.

Executive functioning was assessed through the Behavior Rating Inventory of Executive Functioning 48 (63 items; for 6- to 8-year-olds) or Behavior Rating Inventory of Executive Functioning–Preschool version 49 (63 items; for 4- and 5-year-olds) which was completed by parents and teachers.

Children’s health-related quality of life was assessed through the Child Health Questionnaire–Parent Form-50 50 (50 items).

School absence was assessed through the Rotterdam Quality of Life interview. 45

Children’s enjoyment of physical activity was assessed through an adjusted version of the Groningen Enjoyment Questionnaire 51 , 52 (10 items) which was completed by parents and teachers. The sentencing of the Groningen Enjoyment Questionnaire items was adjusted to enable parents and teachers to fill out the questionnaire (e.g., “This child likes being physically active” instead of “I like being physically active”). In addition to the Groningen Enjoyment Questionnaire, children themselves were asked to answer two questions indicating their enjoyment of physical activity and how often per week they engage in physical activity.

Parental and family outcomes

Parental mental health was the primary parental outcome and was assessed through the Symptom Checklist-90-Revised 53 (90 items), which measures symptom severity of mental health problems.

Excessiveness and uncontrollability of parental worry were assessed through the Penn State Worry Questionnaire 54 , 55 (16 items).

Parenting stress was assessed through the short version of the Nijmeegse Ouderlijke Stress Index 56 (25 items) and the Distress Thermometer-P 57 (42 items).

Parents’ health-related quality of life was assessed through the Short-form (36) Health Survey 58 (36 items).

Family functioning was assessed through the general functioning subscale of the Family Assessment Device 59 (12 items).

Parents’ knowledge about CHD (10 items) were assessed through the Rotterdam Knowledge Questionnaire for Congenital Heart Disease. 52 , 60

Program satisfaction was assessed through a social validity questionnaire that parents completed 2 weeks after CHIP-Family and at 6-month follow-up.

Statistical analyses

Differences in baseline participant characteristics between the CHIP-Family and the care-as-usual groups were examined using t-tests, chi-square tests, and Fisher’s exact tests, where appropriate.

To determine the effectiveness of the CHIP-Family intervention, we compared the differences in change in parent- and child-reported outcomes over time between the CHIP-Family and care-as-usual group using generalised estimating equations. 61 The generalised estimating equation analysis accounts for the dependency between repeated observations and accommodates missing values. 62 The analyses were performed on an intention-to-treat basis. Patients were included in an analysis if an outcome was available at one or both assessment moments. For each outcome, we conducted separate generalised estimating equation analyses. The interaction between time and group (i.e., CHIP-Family versus care as usual) was examined as the test of effectiveness of CHIP-Family. We selected a normal distribution and an identity link function for the majority of outcomes. The Symptom Checklist-90-Revised total score, Distress Thermometer-P total score, Short Form-36 physical component score, pleasure in sports reported by children, and sports participation per week were not normally distributed. Therefore, for these outcomes a gamma distribution with log link function was used.

Teacher-reported outcomes were only assessed at follow-up. We used t-tests to compare the difference in teacher-reported continuous outcomes between the CHIP-Family and care-as-usual group. Because the majority of children had not been absent from school the past month, school absence was dichotomised into 0 days absent and ≥1 day absent and presented as percentage. To compare the difference in school absence between the CHIP-Family and care-as-usual group, chi-square tests were applied.

For the primary outcome variables (Child Behavior Checklist and Symptom Checklist-90-R), the significance level was set at α = 0.05. To adjust for multiple testing within the secondary outcome variables of the child domain and the parental and family domain, we used a Bonferroni correction. In both domains, 17 tests were conducted. Therefore, results with p < 0.003 were considered statistically significant. All statistical analyses were performed using SPSS version 24. 63 Sample size calculations can be found in a previous publication of the study design. 38

Results

Participant characteristics

In total, 93 children were randomised into either the CHIP-Family (n = 49) or the care-as-usual group (n = 44). Non-participants’ cardiac diagnosis and gender were only available for patients of the Erasmus MC–Sophia Children’s Hospital (86.6% of eligible patients) and not for patients contacted via the Dutch Patient Association for Congenital Heart Disease (13.4% of eligible patients). Participants and non-participants from the Erasmus MC–Sophia Children’s Hospital did not differ as to CHD severity (p = 0.06) and gender (p = 0.12). Other demographic data were not available.

Parents of three children did not complete any questionnaires after randomisation. Therefore, the final sample consisted of 90 children (n = 47 CHIP-Family, n = 43 care as usual). The CHIP-Family and care-as-usual group did not differ from each other in terms of age, gender, CHD type, school year, recruitment centre, comorbid physical illness, family composition, or social economic status (see Table 2), which indicates that randomisation was successful. Four children were referred for further psychological care after participating in the CHIP-Family intervention (n = 44) and received this care after completion of the follow-up assessment. Problems such as anxiety and emotion regulation issues were noted in these children during the group workshop and/or individual follow-up session.

Table 2. Baseline participant characteristics.

* t-test

** Chi-square test

*** Limited to none: atrial septal defect, patent ductus arteriosus, pulmonary valve stenosis, total anomalous pulmonary venous connection, ventricular septal defect. Mild, moderate, severe: anomalous left coronary artery from the pulmonary artery, atrioventricular septal defect, coarctation of the aorta, complex biventricular (e.g., truncus arteriosus, aortic arch defects with ventricular septal defect), univentricular heart defects – Fontan circulation, Ebstein’s anomaly (sub)valvular aortic stenosis, Tetralogy of Fallot (TOF) including main aorta to pulmonary connecting artery, transposition of the great arteries

**** Fisher’s exact test

***** Low: primary education, lower vocational education, lower or middle general secondary education; intermediate: middle vocational education, higher secondary education, pre-university education; high: higher vocational education, university

Protocol adherence

Workshops

Five families randomised into the CHIP-Family group did not participate in the CHIP-Family intervention. Of these five families, one family declined to participate in CHIP-Family and four families were unable to attend the intervention due to practical reasons. In total, 44 families participated in the CHIP-Family workshops. One family discontinued the intervention after approximately 1 hour, because the child was upset.

Of 34 (77.3%) families, both parents participated in the workshop. Of the remaining 10 (22.7%) families, only the mother participated in the workshop. Twenty-eight (63.7%) children participated in the workshop with a sibling, 6 (13.6%) children participated with a friend, and 10 (22.7%) children participated without a sibling or friend. In nine parent workshops and seven child workshops, all the protocol topics were discussed. In the remaining two parent workshops and four child workshops, 96% of the protocol topics was discussed. This indicates excellent protocol adherence.

Follow-up sessions

Of all families, at least one parent attended the follow-up session. Four psychology master’s students rated protocol adherence of a randomly selected 50% of the follow-up sessions. On average, 87% of the protocol topics was discussed in the randomly selected follow-up sessions.

Outcomes

Child, parental, and family outcomes are summarised in Tables 3 and 4. No statistically significant differences between the CHIP-Family and care-as-usual group were found in both the child outcomes (reported by children, mothers, fathers, and teachers) and the parental and family outcomes (reported by mothers and fathers).

Table 3. Child outcomes.

BRIEF-P = Behavior Rating Inventory of Executive Functioning–Preschool version; CBCL = Child Behavior Checklist; CHIP = Congenital Heart Disease Intervention Program; CHQ-PF50 = Child Health Questionnaire–Parent Form-50; GEE = generalised estimating equation; GEQ = Groningen Enjoyment Questionnaire; TRF-C = Teacher’s Report Form-C

Values are mean ± SD, unless otherwise specified

* A higher score indicates more problems or poorer functioning

** GEE analysis. p-Value indicates the level of significance of the interaction between condition and follow-up time

*** Cohen’s d = (MCHIP_T2 – MCAU_T2)/SDpooled. SDpooled = √((SDCHIP_T2 2 + SDCAU_T2 2)/2)

**** T-test

***** A higher score indicates less problems or better functioning

****** Chi-square test

******* Phi coefficient

Table 4. Parental and family outcomes.

DT-P = Distress Thermometer-P; FAD = Family Assessment Device; NOSIK = Nijmeegse Ouderlijke Stress Index; PSWQ = Penn State Worry Questionnaire; SCL-90-R = Symptom Checklist-90-Revised; SF-36=Short-form (36) Health Survey

Values are mean ± SD. p-Values indicate the level of significance of the interaction between condition and follow-up time

* A higher score indicates more problems or poorer functioning

** A higher score indicates less problems or better functioning

*** A higher score indicates more disease-specific knowledge (maximum score = 14)

Despite successful randomisation, the baseline difference in the Child Behavior Checklist total scores reported by mothers was statistically significant (p = 0.001), such that mothers in the CHIP-Family group reported more child emotional and behavioural problems at baseline than mothers in the care-as-usual group. No other baseline differences in outcomes were found. For both the CHIP-Family and the care-as-usual group, the Child Behavior Checklist total scores reported by both mothers and fathers significantly decreased from baseline to follow-up (p = 0.001 and p < 0.001).

Program acceptability

Thirty-one (70.5%) mothers and 26 (76.5%) fathers who participated in CHIP-Family rated program acceptability at 6-month follow-up. On a scale of 0–10, mean overall usefulness rating was 7.5 (SD = 1.6) and 7.8 (SD = 1.5), respectively, for the parent and child workshop. Mean satisfaction rating was 7.7 (SD = 1.2) and 8.1 (SD = 1.3) for the parent and child workshop, respectively. Mean rating of the usefulness of the individual follow-up session was 7.4 (SD = 1.5). Mean rating of the likeliness that parents would recommend CHIP-Family to other families of children with CHD was 7.7 (SD = 1.5). Parents were asked to rate the components of CHIP-Family that they found most useful (see Fig 2). Most parents perceived the psychosocial and medical explanation of the paediatric cardiologist (72.7%), meeting other families of children with CHD (61.8%), the child workshop (50.9%), and receiving skills tailored to parenting children with CHD (43.6%) as the most useful elements of the intervention. At follow-up, a substantial percentage of parents (47.7%) reported using the techniques learnt in CHIP-Family sometimes (monthly).

Figure 2. Parents’ ratings of most useful components of the Congenital Heart Disease Intervention Program (CHIP)-Family intervention (multiple answers possible).

Parents of children with less severe CHD (i.e., limited to no residual heart defects after cardiac intervention; see Table 1) rated usefulness of the child workshop more favourably (M = 8.4, SD = 1.6) compared to parents of children with more severe CHD (i.e., mild to severe residual heart defects after cardiac intervention; see Table 1; M = 7.4, SD = 1.4), t(53) = 2.23, p = 0.03. Parents of children with less severe CHD also rated satisfaction with the child workshop more favourably (M = 8.6, SD = 1.3) compared to parents of children with more severe CHD (M = 7.8, SD = 1.2), t(53) = 2.47, p = 0.02.

Discussion

The aim of the current randomised controlled trial was to examine the effect of the multidisciplinary, psychosocial CHIP-Family intervention on psychosocial well-being of young children with CHD and their families. Parents evaluated usefulness of and satisfaction with CHIP-Family positively. Moreover, through CHIP-Family, the involved mental healthcare professionals were able to identify four children who had psychosocial issues that required additional psychological care. These psychosocial issues might otherwise have remained unnoticed and untreated. However, our findings indicate that, compared with care as usual, participation in CHIP-Family did not significantly improve the psychosocial well-being of children with CHD and their families at 6-month follow-up. This is in contrast with the results of the previously examined CHIP-School intervention, which yielded more positive results at 10-month follow-up. 36

The culture of replicability research in psychological interventions in general is poor and publication bias often amplifies the problem. 64 However, replication studies are important not only to confirm or question the impact of an intervention but rather to yield important information to further refine interventions and evaluation protocols. Thus, Stehl and colleagues 65 found that a similar family-focused intervention for parents of children with cancer, whilst successful later in the illness trajectory, yielded less impressive outcomes when delivered earlier in the illness cycle – despite the promising theoretical reasons why it might be even more effective. Law and colleagues’ 66 meta-analysis highlighted generally small to moderate effect sizes, and parental functioning in family-focused interventions ultimately aimed at improving outcomes for the child. Again, important lessons in intervention focus and measurements used were discussed.

Following the results of the present study, we were interested in considering differences between CHIP-Family and the previous CHIP-School on which it was based, and what these might tell us about future interventions and evaluations. Two classes of differences may be important:

  • The intervention – Some key differences may have been important. Firstly, as noted above, CHIP-School comprised a behavioural experiment – the bicycle exercise test – to directly challenge assumptions about fragility and poor exercise capacity. For logistical reasons, ours did not. CHIP-School authors noted that parents had rated this component as the most helpful (personal communication). Secondly, we incorporated parallel workshops for children and siblings. Whilst theoretically we expected this to enhance impact, having their children attend the same day may in fact have diluted the importance of, and engagement with, the primacy of the parent focus of the intervention. It should be noted, however, that parents did rate the child workshop positively. Finally, we had smaller groups of parents (three to five) compared to CHIP-School. Again, we expected this to enhance impact, but such may also have moderated the social facilitation and support impact of the groups.

  • The sample – In CHIP-Family, we had lower rates of uptake (24%) compared to CHIP-School (60%). Although our responders seemed similar to non-responders (see above) on CHD severity measures, our samples may have differed on other important psychosocial ways which our studies are not able to compare but which relate to the issue of targeting such interventions. It is difficult to draw clear conclusions here, but this merits consideration in future research. CHIP-School targeted families just before the child made the transition to school, whereas CHIP-Family included families of children who had already started school. Drotar 67 makes the case for timing of early interventions at the cusp of developmental transitions and this may be important.

As CHIP-Family was designed as a preventive intervention, patients and their families were not selected for participation in the randomised controlled trial based on their level of psychosocial difficulties. Considering the baseline scores, participants seemed to be functioning relatively well. That is, compared with the general population, all mean scores fell within the normal range. One might expect that baseline scores would have been higher if we would have included only children with severe or complex CHD. However, a meta-analysis 8 has shown that disease severity in children with CHD is not related to internalising, externalising, and overall emotional and behavioural problems. Also, the majority of parents were highly educated. Significant improvements might have been found if we provided CHIP-Family specifically to patients and families who suffered from clinically significant psychosocial difficulties.

Moreover, besides issues related to early childhood, several topics were discussed in the CHIP-Family intervention, concerning future issues related to adolescence and young adulthood, such as alcohol use, smoking, sexuality, insurances, and career possibilities. This was done to provide parents an overall future perspective and also to encourage parents to ask for advice or help from the medical staff. Furthermore, these were topics often addressed by parents during the intervention. Whether this kind of psychoeducation has positive effects when these children reach adolescence could not be assessed within the shorter 6-month follow-up period.

Remarkably, although no differences in participant characteristics were found between the CHIP-Family and the care-as-usual group, a baseline difference was found in child emotional and behavioural problems reported by mothers. Mothers in the CHIP-Family group reported more child emotional and behavioural problems than mothers in the care-as-usual group. This might be explained by the fact that participants were aware of randomisation outcome prior to baseline assessment. Due to logistical reasons, this could not be arranged otherwise. Parents might have psychologically prepared for the CHIP-Family intervention by reflecting on questions they wanted to discuss, which may have increased their awareness of problems and, consequently, increased their problem reports.

Moreover, we found that both mother reports and father reports of the Child Behavior Checklist questionnaire in the care-as-usual and CHIP-Family group improved similarly over time. This might be explained by the “question–behaviour effect”. That is, behaviour of participants can be affected by merely filling out questionnaires, 68 which was done by parents of children in both the care-as-usual and the CHIP-Family group. Furthermore, the information letters sent to potential participants contained information on common psychosocial issues in young children with CHD. Reading this information may have had a normalising effect. Also, perhaps the feeling of receiving more attention from the hospital staff by participating in the study may have contributed to positive outcomes for both groups.

Interestingly, we found that parents of children with less severe CHD rated the usefulness of and satisfaction with the child workshop more favourably than parents of children with more severe CHD. This could be attributed to the fact that children with less severe CHD make less outpatient clinic visits compared to children with more severe CHD. Parents of children who make less clinic visits might appreciate the attention of healthcare professionals more compared to parents of children who are accustomed to more frequent visits to clinic. Alternatively, parents of children with more severe CHD might prefer a different child intervention program than parents of children with less severe CHD.

Strengths and limitations

This study has several strengths. Worldwide CHIP-Family is the first psychosocial intervention for children with CHD, which is comprised of both a specific child and parent module. Protocol adherence was strong. Moreover, fathers are underrepresented in paediatric research and, when fathers are included, mothers’ and fathers’ reports often are not analysed separately. 69 , 70 Both mothers and fathers participated in CHIP-Family and their outcome reports were analysed separately.

A number of limitations should also be considered. Firstly, as mentioned above, informing participants of randomisation outcome prior to the baseline assessment may have influenced the results. Secondly, due to the nature of the intervention, it was not possible to blind participants for group status. Thirdly, the differences in outcome scores in favour of the CHIP-Family group might have been statistically significant if the sample size would have been larger. Finally, perhaps we would have found larger effects if we had used more disease-specific questionnaires related to family functioning and worry. However, at the start of this study, these tools were not available in Dutch.

Conclusion

In summary, CHIP-Family was evaluated positively by participants and seems to meet parents’ and patients’ needs. However, the intervention did not significantly improve the psychosocial well-being of young children with CHD and their families at 6-month follow-up. As CHIP-Family did not meet its expectations, future research should focus on which patients and families will benefit most from a psychosocial intervention. Future research should also examine whether intervention programs should be adjusted according to CHD severity. Moreover, alternative formats in which psychosocial interventions may be provided could be considered, such as easily accessible online psychoeducation or group videoconferences. Also, psychosocial topics could be integrated into shared medical appointments, 71 which show promising results.

Acknowledgements

We are grateful to all families that participated in this trial and thank the Dutch Patient Association for Congenital Heart Disease for their advice and their help in facilitating the conduct of this trial. We also thank all psychologists, paediatric cardiologists, physiotherapists, and master’s students for their efforts in providing the CHIP-Family intervention.

Financial Support

This work was supported by Fonds NutsOhra, Amsterdam, the Netherlands (grant number 101.083). The funding source had no role in the design of the study, its execution, analysis, interpretation of the data, or decision to submit results.

Conflicts of Interest

None.

Ethical Standards

The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national guidelines on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008, and has been approved by Medical Ethics Committee of the Erasmus Medical Center. Informed consent was obtained from all patients in accordance with the university hospital policies.

References

1. Torowicz, D, Irving, SY, Hanlon, AL, Fullbright Sumpter, D, Medoff-Cooper, B. Infant temperament and parent stress in 3 month old infants following surgery for complex congenital heart disease. J Dev Behav Pediatr 2010; 31: 202208.
2. Solberg, O, Dale, MT, Holmstrom, H, Eskedal, LT, Landolt, MA, Vollrath, ME. Emotional reactivity in infants with congenital heart defects and maternal symptoms of postnatal depression. Arch Womens Ment Health 2011; 14: 487492.
3. Brosig, CL, Mussatto, KA, Kuhn, EM, Tweddell, JS. Psychosocial outcomes for preschool children and families after surgery for complex congenital heart disease. Pediatr Cardiol 2007; 28: 255262.
4. Bellinger, DC, Newburger, JW, Wypij, D, Kuban, KC, duPlesssis, AJ, Rappaport, LA. Behaviour at eight years in children with surgically corrected transposition: the Boston circulatory arrest trial. Cardiol Young 2009; 19: 8697.
5. Martinez-Biarge, M, Jowett, VC, Cowan, FM, Wusthoff, CJ. Neurodevelopmental outcome in children with congenital heart disease. Semin Fetal Neonatal Med 2013; 18: 279285.
6. Puosi, R, Korkman, M, Sarajuuri, A, et al. Neurocognitive development and behavioral outcome of 2-year-old children with univentricular heart. J Int Neuropsychol Soc 2011; 17: 10941103.
7. Hovels-Gurich, HH, Konrad, K, Skorzenski, D, et al. Long-term behavior and quality of life after corrective cardiac surgery in infancy for tetralogy of Fallot or ventricular septal defect. Pediatr Cardiol 2007; 28: 346354.
8. Karsdorp, PA, Everaerd, W, Kindt, M, Mulder, BJ. Psychological and cognitive functioning in children and adolescents with congenital heart disease: a meta-analysis. J Pediatr Psychol 2007; 32: 527541.
9. McCusker, CG, Armstrong, MP, Mullen, M, Doherty, NN, Casey, FA. A sibling-controlled, prospective study of outcomes at home and school in children with severe congenital heart disease. Cardiol Young 2013; 23: 507516.
10. Calderon, J, Bonnet, D, Pinabiaux, C, Jambaque, I, Angeard, N. Use of early remedial services in children with transposition of the great arteries. J Pediatr 2013; 163: 11051110.
11. Riehle-Colarusso, T, Autry, A, Razzaghi, H, et al. Congenital heart defects and receipt of special education services. Pediatrics 2015; 136: 496504.
12. Gerstle, M, Beebe, DW, Drotar, D, Cassedy, A, Marino, BS. Executive functioning and school performance among pediatric survivors of complex congenital heart disease. J Pediatr 2016; 173: 154159.
13. Shillingford, AJ, Glanzman, MM, Ittenbach, RF, Clancy, RR, Gaynor, JW, Wernovsky, G. Inattention, hyperactivity, and school performance in a population of school-age children with complex congenital heart disease. Pediatrics 2008; 121: 759767.
14. Farr, SL, Downing, KF, Riehle-Colarusso, T, Abarbanell, G. Functional limitations and educational needs among children and adolescents with heart disease. Congenit Heart Dis 2018; 13: 633639.
15. Bellinger, DC, Wypij, D, duPlessis, AJ, et al. Neurodevelopmental status at eight years in children with dextro-transposition of the great arteries: the Boston Circulatory Arrest Trial. J Thorac Cardiovasc Surg 2003; 126: 13851396.
16. Cassidy, AR, Ilardi, D, Bowen, SR, et al. Congenital heart disease: a primer for the pediatric neuropsychologist. Child Neuropsychol 2017: 144.
17. Spijkerboer, AW, Utens, EM, Bogers, AJ, Helbing, WA, Verhulst, FC. A historical comparison of long-term behavioral and emotional outcomes in children and adolescents after invasive treatment for congenital heart disease. J Pediatr Surg 2008; 43: 534539.
18. Ringle, ML, Wernovsky, G. Functional, quality of life, and neurodevelopmental outcomes after congenital cardiac surgery. Semin Perinatol 2016; 40: 556570.
19. Bellinger, DC, Newburger, JW. Neuropsychological, psychosocial, and quality-of-life outcomes in children and adolescents with congenital heart disease. Progr Pediatr Cardiol 2010; 29: 8792.
20. Schaefer, C, von Rhein, M, Knirsch, W, et al. Neurodevelopmental outcome, psychological adjustment, and quality of life in adolescents with congenital heart disease. Dev Med Child Neurol 2013; 55: 11431149.
21. Kovacs, AH, Moons, P. Psychosocial functioning and quality of life in adults with congenital heart disease and heart failure. Heart Fail Clin 2014; 10: 3542.
22. Holbein, CE, Fogleman, ND, Hommel, K, et al. A multinational observational investigation of illness perceptions and quality of life among patients with a Fontan circulation. Congenit Heart Dis 2018; 13: 392400.
23. McCrindle, BW, Williams, RV, Mital, S, et al. Physical activity levels in children and adolescents are reduced after the Fontan procedure, independent of exercise capacity, and are associated with lower perceived general health. Arch Dis Child 2007; 92: 509514.
24. Massin, MM, Hovels-Gurich, HH, Gerard, P, Seghaye, MC. Physical activity patterns of children after neonatal arterial switch operation. Ann Thorac Surg 2006; 81: 665670.
25. Dulfer, K, Helbing, WA, Duppen, N, Utens, EM. Associations between exercise capacity, physical activity, and psychosocial functioning in children with congenital heart disease: a systematic review. Eur J Prev Cardiol 2014; 21: 12001215.
26. Duppen, N, Takken, T, Hopman, MT, et al. Systematic review of the effects of physical exercise training programmes in children and young adults with congenital heart disease. Int J Cardiol 2013; 168: 17791787.
27. Voss, C, Duncombe, SL, Dean, PH, de Souza, AM, Harris, KC. Physical activity and sedentary behavior in children with congenital heart disease. J Am Heart Assoc 2017; 6: e004665.
28. Casey, FA, Stewart, M, McCusker, CG, et al. Examination of the physical and psychosocial determinants of health behaviour in 4-5-year-old children with congenital cardiac disease. Cardiol Young 2010; 20: 532537.
29. McCusker, CG, Doherty, NN, Molloy, B, et al. Determinants of neuropsychological and behavioural outcomes in early childhood survivors of congenital heart disease. Arch Dis Child 2007; 92: 137141.
30. Woolf-King, SE, Anger, A, Arnold, EA, Weiss, SJ, Teitel, D. Mental health among parents of children with critical congenital heart defects: a systematic review. J Am Heart Assoc 2017; 6: e004862.
31. Kolaitis, GA, Meentken, MG, Utens, E. Mental health problems in parents of children with congenital heart disease. Front Pediatr 2017; 5: 102.
32. McClung, N, Glidewell, J, Farr, SL. Financial burdens and mental health needs in families of children with congenital heart disease. Congenit Heart Dis 2018; 13: 554562.
33. Lesch, W, Specht, K, Lux, A, Frey, M, Utens, E, Bauer, U. Disease-specific knowledge and information preferences of young patients with congenital heart disease. Cardiol Young 2014; 24: 321330.
34. Levert, EM, Helbing, WA, Dulfer, K, van Domburg, RT, Utens, EM. Psychosocial needs of children undergoing an invasive procedure for a CHD and their parents. Cardiol Young 2017; 27: 243254.
35. Tesson, S, Butow, PN, Sholler, GF, Sharpe, L, Kovacs, AH, Kasparian, NA. Psychological interventions for people affected by childhood-onset heart disease: a systematic review. Health Psychol 2019; 38: 151161.
36. McCusker, CG, Doherty, NN, Molloy, B, et al. A randomized controlled trial of interventions to promote adjustment in children with congenital heart disease entering school and their families. J Pediatr Psychol 2012; 37: 10891103.
37. Thompson, RJ Jr., Gustafson, KE, Hamlett, KW, Spock, A. Stress, coping, and family functioning in the psychological adjustment of mothers of children and adolescents with cystic fibrosis. J Pediatr Psychol 1992; 17: 573585.
38. van der Mheen, M, van Beynum, IM, Dulfer, K, et al. The CHIP-Family study to improve the psychosocial wellbeing of young children with congenital heart disease and their families: design of a randomized controlled trial. BMC Pediatr 2018; 18: 230.
39. Saigal, S and Doyle, LW. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet 2008; 371: 261269.
40. Hoffman, JI, Kaplan, S. The incidence of congenital heart disease. J Am Coll Cardiol 2002; 39: 18901900.
41. Utens, E, Dulfer, K, Legerstee, J, Van Beynum, I, Meentken, M, Van der Mheen, M. Dutch translation of: Beyond the Diagnosis: Family Adaptation to Congenital Heart Disease. Erasmus MC – Sophia Children’s Hospital, Rotterdam, 2016.
42. Utens, EMWJ. FIJN: VRIENDEN! Handleiding voor ouders om emotionele veerkracht door middel van spel op te bouwen bij 4 tot en met 7 jarigen. Erasmus MC – Sophia Kinderziekenhuis, Rotterdam, 2011.
43. Barrett, PM. Fun FRIENDS: The Teaching and Training Manual for Group Leaders. Fun FRIENDS Publishing, Brisbane, 2007.
44. Dulfer, K, Duppen, N, Kuipers, IM, et al. Aerobic exercise influences quality of life of children and youngsters with congenital heart disease: a randomized controlled trial. J Adolesc Health 2014; 55: 6572.
45. Utens, E, Dulfer, K. Rotterdams Kwaliteit van Leven Interview. 2010.
46. Achenbach, TM, Rescorla, LA. Manual for the ASEBA School-Age Forms & Profiles. University of Vermont, Research Center for Children, Youth, & Families, Burlington, Vermont, 2001.
47. Verhulst, FC, van der Ende, J. Handleiding ASEBA Vragenlijsten voor leeftijden 6 tot en met 18 jaar. ASEBA, Rotterdam, The Netherlands, 2013.
48. Smidts, DP, Huizinga, M. BRIEF Executieve Functies Gedragsvragenlijst: Handleiding. Hogrefe Uitgevers, Amsterdam, 2009.
49. Van der Heijden, KB, Suurland, J, De Sonneville, LMJ, Swaab, HJT. BRIEF-P Vragenlijst executieve functies voor 2- tot 5-jarigen. Hogrefe uitgevers, Amsterdam, 2013.
50. Langraf, JM, Abetz, L, Ware, JE. The CHQ User’s Manual. Health Act, Boston, 1999.
51. Stevens, M, Moget, P, de Greef, MH, Lemmink, KA, Rispens, P. The Groningen Enjoyment Questionnaire: a measure of enjoyment in leisure-time physical activity. Percept Mot Skills 2000; 90: 601604.
52. Dulfer, K, Duppen, N, Blom, NA, et al. Effect of exercise training on sports enjoyment and leisure-time spending in adolescents with complex congenital heart disease: the moderating effect of health behavior and disease knowledge. Congenit Heart Dis 2014; 9: 415423.
53. Arrindell, WA, Ettema, JHM. SCL-90. Symptom Checklist. Handleiding bij een multidimensionele psychopathologie-indicator. Swets Test Publishers, Lisse, 2003.
54. Meyer, TJ, Miller, ML, Metzger, RL, Borkovec, TD. Development and validation of the Penn State Worry Questionnaire. Behav Res Ther 1990; 28: 487495.
55. Van der Heiden, C, Muris, P, Bos, AE, Van der Molen, HT. Factor structure of the Dutch version of the Penn State Worry Questionnaire. J Behav Ther Exp Psych 2010; 41: 304309.
56. De Brock, AJLL, Vermulst, AA, Gerris, JRM, Abidin, RR. NOSI: Nijmeegse Ouderlijke Stress Index, handleiding experimentele versie. Swets & Zeitlinger, Lisse, 1992.
57. Haverman, L, van Oers, HA, Limperg, PF, et al. Development and validation of the distress thermometer for parents of a chronically ill child. J Pediatr 2013; 163: 11401146 e1142.
58. Aaronson, NK, Muller, M, Cohen, PD, et al. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 1998; 51: 10551068.
59. Epstein, NB, Baldwin, LM, Bishop, DS. The McMaster family assessment device. J Marital Fam Ther 1983; 9: 171180.
60. Utens, EMWJ, Dulfer, K. Rotterdam Knowledge Questionnaire. Erasmus MC - Sophia Children’s Hospital, Rotterdam, 2010.
61. Zeger, SL, Liang, KY, Albert, PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics 1988; 44: 10491060.
62. Twisk, JW. Longitudinal data analysis. A comparison between generalized estimating equations and random coefficient analysis. Eur J Epidemiol 2004; 19: 769776.
63. Corp, I. IBM SPSS Statistics for Windows. IBM Corp, Armonk, NY, 2016.
64. Hughes, B. Psychology in Crisis. Macmillan International Higher Education, London, 2018.
65. Stehl, ML, Kazak, AE, Alderfer, MA, et al. Conducting a randomized clinical trial of an psychological intervention for parents/caregivers of children with cancer shortly after diagnosis. J Pediatr Psychol 2009; 34: 803816.
66. Law, EF, Fisher, E, Fales, J, Noel, M, Eccleston, C. Systematic review and meta-analysis of parent and family-based interventions for children and adolescents with chronic medical conditions. J Pediatr Psychol 2014; 39: 866886.
67. Drotar, D. Psychological Interventions in Childhood Chronic Illness. American Psychological Association, Washington DC, 2006.
68. Wilding, S, Conner, M, Sandberg, T, et al. The question-behaviour effect: a theoretical and methodological review and meta-analysis. Eur Rev Soc Psychol 2016; 27: 196230.
69. Phares, V, Lopez, E, Fields, S, Kamboukos, D, Duhig, AM. Are fathers involved in pediatric psychology research and treatment? J Pediatr Psychol 2005; 30: 631643.
70. Parent, J, Forehand, R, Pomerantz, H, Peisch, V, Seehuus, M. Father participation in child psychopathology research. J Abnorm Child Psychol 2017; 45: 12591270.
71. Kirsh, SR, Aron, DC, Johnson, KD, et al. A realist review of shared medical appointments: how, for whom, and under what circumstances do they work? BMC Health Serv Res 2017; 17: 113.